Screening for cognitive deficits with the Evaluation of Cognitive Processes involved in Disability in Schizophrenia scale.


Journal

Clinical rehabilitation
ISSN: 1477-0873
Titre abrégé: Clin Rehabil
Pays: England
ID NLM: 8802181

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 18 7 2018
medline: 10 7 2019
entrez: 18 7 2018
Statut: ppublish

Résumé

This study aimed to evaluate the validity of the Evaluation of Cognitive Processes involved in Disability in Schizophrenia scale (ECPDS) to discriminate for cognitive impairment in schizophrenia. This multicentre cross-sectional study used a validation design with receiver operating characteristic (ROC) curve analysis. The study was undertaken in a French network of seven outward referral centres. We recruited individuals with clinically stable schizophrenia diagnosed based on the Structured Clinical Interview for assessing Diagnostic and Statistical Manual of Mental Disorders (4th ed., rev.; DSM-IV-R) criteria. The index test for cognitive impairment was ECPDS (independent variable), a 13-item scale completed by a relative of the participant. The reference standard was a standardized test battery that evaluated seven cognitive domains. Cognitive impairment was the dependent variable and was defined as an average z-score more than 1 SD below the normative mean in two or more cognitive domains. Overall, 97 patients were included (67 with schizophrenia, 28 with schizoaffective disorder, and 2 with schizophreniform disorder). The mean age was 30.2 (SD 7.7) years, and there were 75 men (77.3%). There were 59 (60.8%) patients with cognitive impairment on the neuropsychological battery, and the mean ECPDS score was 27.3 (SD 7.3). The ROC curve analysis showed that the optimal ECPDS cut-off was 29.5. The area under the curve was 0.77, with 76.3% specificity and 71.1% sensitivity to discriminate against cognitive impairment. The ECPDS is a valid triage tool for detecting cognitive impairment in schizophrenia, before using an extensive neuropsychological battery, and holds promise for use in everyday clinical practice.

Identifiants

pubmed: 30012064
doi: 10.1177/0269215518787324
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-119

Auteurs

Paul Roux (P)

1 Fondation FondaMental, Créteil, France.
2 Department of Adult Psychiatry, Versailles Hospital, Le Chesnay, France.
3 HandiRESP Laboratory, EA4047, Health Sciences Department Simone Veil, University of Versailles Saint-Quentin-En-Yvelines, Montigny-le-Bretonneux, France.

Mathieu Urbach (M)

1 Fondation FondaMental, Créteil, France.
2 Department of Adult Psychiatry, Versailles Hospital, Le Chesnay, France.
3 HandiRESP Laboratory, EA4047, Health Sciences Department Simone Veil, University of Versailles Saint-Quentin-En-Yvelines, Montigny-le-Bretonneux, France.

Sandrine Fonteneau (S)

1 Fondation FondaMental, Créteil, France.
2 Department of Adult Psychiatry, Versailles Hospital, Le Chesnay, France.
3 HandiRESP Laboratory, EA4047, Health Sciences Department Simone Veil, University of Versailles Saint-Quentin-En-Yvelines, Montigny-le-Bretonneux, France.

Fabrice Berna (F)

1 Fondation FondaMental, Créteil, France.
4 Strasbourg University Hospital, INSERM U1114, Strasbourg Federation of Translational Psychiatry, University of Strasbourg, Strasbourg, France.

Lore Brunel (L)

1 Fondation FondaMental, Créteil, France.
5 INSERM U955, Translational Psychiatry Team, Université Paris-Est Créteil (UPEC), AP-HP, DHU Pe-PSY, Department of Adult Psychiatry, Henri Mondor University Hospitals, Créteil, France.

Delphine Capdevielle (D)

1 Fondation FondaMental, Créteil, France.
6 University Department of Adult Psychiatry, La Colombière Hospital, CHU Montpellier, University of Montpellier 1, INSERM 1061, Montpellier, France.

Isabelle Chereau (I)

1 Fondation FondaMental, Créteil, France.
7 CMP B, Clermont-Ferrand University Hospital, EA 7280, Faculty of Medicine, Auvergne University, Clermont-Ferrand Cedex 1, France.

Julien Dubreucq (J)

1 Fondation FondaMental, Créteil, France.
8 Psychosocial Rehabilitation Reference Centre, Alpes Isère Hospital, Grenoble, France.

Catherine Faget-Agius (C)

1 Fondation FondaMental, Créteil, France.
9 Academic Department of Psychiatry (AP-HM), Sainte-Marguerite University Hospital, Marseille, France.

Guillaume Fond (G)

1 Fondation FondaMental, Créteil, France.

Sylvain Leignier (S)

1 Fondation FondaMental, Créteil, France.
8 Psychosocial Rehabilitation Reference Centre, Alpes Isère Hospital, Grenoble, France.

Claire-Cécile Perier (CC)

1 Fondation FondaMental, Créteil, France.
8 Psychosocial Rehabilitation Reference Centre, Alpes Isère Hospital, Grenoble, France.

Raphaëlle Richieri (R)

1 Fondation FondaMental, Créteil, France.
9 Academic Department of Psychiatry (AP-HM), Sainte-Marguerite University Hospital, Marseille, France.

Priscille Schneider (P)

1 Fondation FondaMental, Créteil, France.
4 Strasbourg University Hospital, INSERM U1114, Strasbourg Federation of Translational Psychiatry, University of Strasbourg, Strasbourg, France.

Franck Schürhoff (F)

1 Fondation FondaMental, Créteil, France.
5 INSERM U955, Translational Psychiatry Team, Université Paris-Est Créteil (UPEC), AP-HP, DHU Pe-PSY, Department of Adult Psychiatry, Henri Mondor University Hospitals, Créteil, France.

Anne Marie Tronche (AM)

1 Fondation FondaMental, Créteil, France.
7 CMP B, Clermont-Ferrand University Hospital, EA 7280, Faculty of Medicine, Auvergne University, Clermont-Ferrand Cedex 1, France.

Hanan Yazbek (H)

1 Fondation FondaMental, Créteil, France.
6 University Department of Adult Psychiatry, La Colombière Hospital, CHU Montpellier, University of Montpellier 1, INSERM 1061, Montpellier, France.

Anna Zinetti-Bertschy (A)

1 Fondation FondaMental, Créteil, France.
4 Strasbourg University Hospital, INSERM U1114, Strasbourg Federation of Translational Psychiatry, University of Strasbourg, Strasbourg, France.

Christine Passerieux (C)

1 Fondation FondaMental, Créteil, France.
2 Department of Adult Psychiatry, Versailles Hospital, Le Chesnay, France.
3 HandiRESP Laboratory, EA4047, Health Sciences Department Simone Veil, University of Versailles Saint-Quentin-En-Yvelines, Montigny-le-Bretonneux, France.

Eric Brunet-Gouet (E)

1 Fondation FondaMental, Créteil, France.
2 Department of Adult Psychiatry, Versailles Hospital, Le Chesnay, France.
3 HandiRESP Laboratory, EA4047, Health Sciences Department Simone Veil, University of Versailles Saint-Quentin-En-Yvelines, Montigny-le-Bretonneux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH